IL-6 anti-inflammatory activity in pleural effusion post-coronary artery bypass graft surgery;Comportamento anti-inflamatório da IL-6 nos derrames pleurais pós-revascularização do miocárdio

Revista Portuguesa de Pneumologia

Volumn 13, Issue 3, 2007, Pages 319-334

  Chibante, António M S ^a,c   Vaz, Marcelo C ^b   Vargas, Francisco Suzo ^b  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Coronary artery bypass graft surgery; IL 6; Pleural effusion

Indexed keywords

ACUTE PHASE PROTEIN; CORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE SYNTHESIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PLEURA EFFUSION; PLEURA FLUID; POSTOPERATIVE PERIOD; PROTEIN ANALYSIS; PROTEIN FUNCTION;

EID: 34547475081     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30352-4     Document Type: Article

References (27)

1. Ishikawa S, Takahashi T, Ohtaki A, Sato Y, Suzuki M, Hasegawa Y, Mohara J, Oshima K Morishita Y. Peripheral pulmonary atelectasis and oxygentation impairment following coronary artery bypass grafting. J Cardiovasc Surg (Torino) 2002;43:419.
2. Vargas FS, Vezhimi KK, Jatene FF, Terra-Filho M, Hueb W, Cukier A, Light RW. Acute pleuropulmonary complications detected by computed tomography following myocardial revascularization. Rev Hosp Clin Fac Med São Paulo 2002;57:135-42.
3. Light RW. Pleural effusions after coronary artery bypass graft surgery. Curr Opin Pulm Med 2002;8:308-11.
4. Ishikawa S, Ohtaki A, Takahashi T, Sakate K, Koyano T, Kano M, Ohkis S, Kawashima O, Hamada Y, Moorishita Y. PEEP therapy for patients with pleurotomy during coronary artery bypass. J Card Surg 2000;15:175-8.
5. Light RW, Rogers JT, Cheng D et al. Large pleural effusions after coronary artery bypassing grafting. Cardiovascular Surgery Associates 1999;130:891-6.
6. Lee YC, Vaz Mac, Ely KA et al. Symptomatic persistent post-coronary artery bypass graft pleural effusion requiring treatment-clinical and histologic features. Chest 2001;119:795-800.
7. Areno JP, McCarteney JP, Eggerstedt J, Grafton W, George R. Persistent pleural effusions following coronary bypass surgery. Chest 1998;114:311-4.
8. Wan S, Marchant A, Desemet JM. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting.J Thorac Cardiovasc Surg 1996; 111:469-77.
9. Gaudino M, Zamparelli R, Andreotti F, Burzotta F, Tacoviello I, Glieca F, Benedett M, Maseri A, Schiavello R, Possati G. Normothermia does not improve postoperative hemostasis nor does it reduce inflammatory activation in patients undergoing primary isolated coronary artery bypass. J Thorac Cardiovasc Surg 2002;123:1092-100.
10. Dinarello CA. Proinflammatory Cytokines. Chest 2000;118:503-8.
11. Kroegel C, Anthony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Ent Respir J 1997;10:2411-18.
12. Xirouchaki N, Tzanakis N, Bouros D, Kyriakou D, Karkavirtsas N, Alexandrakis M, Siafakas NM. Diagnostic value of interleukin-1a, interleukin-6 and tumor necrosis factor in pleural effusions. Chest 2002;121:815-20.
13. Opal SM, De Pablo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-72.
14. Alexandrakis MG, Kuriakou DS, Bouros D, Xylouri I, Antonakis N, Siafakas NM. Interleukin-6 and its relationships to acute phase proteins in serous effusion differentiation. Oncol Respir. 2001;8:415-20.
15. Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999;19:2BB 1427-32.
16. Barton BE. IL-6: insights into novel biological activities. Clin Immunol 1997; 85:16-20.
17. Monton C, Torres A. Lung inflammatory response in pneumonia. Arch Chest Dis 1998;53:56-63.
18. Yokoyama A, Kohno N, Fujino A, Abe M, Ishida O, Hiwada K. Soluble interleukin-6 receptor levels in pleural effusions. Respir Med 1996;90:329-32.
19. Stites D P, Terr AL, Parslow TG. Medical Immunology. 9th ed. Stamford: CT, Appleton and Lange, 1997.
20. Tilg H, Trehu E, Atkins MB. Inteleukin-6 as an anti-inflammatory cytokine: reduction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor. Blood 1994;83:113-8.
21. Ruzek MC, Miller AH, Opal SM. Caracterization of early cytokine responses in an interleukin-6 dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med 1997; 185:1185-92.
22. Xing Z, Gauldie J, Cox G et al. Il-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311-20.
23. Gary-Lee YC, Lane KB. The many faces of transforming growth factor- beta in pleural diseases. Curr Opin Pulm Med 2001; 7:173-9.
24. Grove CS, Lee YC. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 2002;8:294-301.
25. Nasreen N, Mohammed KA, Hardwick J, Van Horn RD, Sanders KL, Doerschuk CM, Hott JW, Antony VB. Polar production of IL-8 by mesothelial cells promotes the transmesothelial immigration of neutrophil: role of intercellular adhesion molecule-1. J Infect Dis 2001; 183:1683-45.
26. Weissflog D, Kroegel C, Luttmann W, Grahmann PR, Hasse J. Leukocyte infiltration and secretion of cytokines in pleural drainage fluid after thoracic surgery. impaired cytokine response in malignancy and postoperative complications. Chest 1999;115:1604-10.
27. Vaz MAC, Chibante AMS, Vargas FS. Cytokines in Pleural Effusions in First 48 hours after Coronary Artery Bypass Surgery (CABG). Chest 2004;126:8965-8969S.